XOMA vs URGN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

XOMA

55.8
AI Score
VS
XOMA Wins

URGN

54.9
AI Score

Investment Advisor Scores

XOMA

56score
Recommendation
HOLD

URGN

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric XOMA URGN Winner
Revenue 38.39M 50.96M URGN
Net Income 25.61M -23.57M XOMA
Net Margin 66.7% -46.3% XOMA
Operating Income 9.20M -20.26M XOMA
ROE 29.1% 19.0% XOMA
ROA 9.7% -9.3% XOMA
Total Assets 263.15M 253.69M XOMA
Cash 45.19M 109.97M URGN
Debt/Equity 1.07 -1.61 URGN
Current Ratio 3.91 4.69 URGN

Relative Price Performance (Last 90 Days)

XOMA 1M: -3.8% · 3M: +9.3% URGN 1M: +2.2% · 3M: +68.9%

Current Technical Phase

XOMA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 34.5 · Price: $40.17

URGN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (18.4% over 20 days), RSI 51

RSI (14): 51.0 · Price: $38.85

Fundamentals Snapshot

Metric XOMA URGN
Market Cap
Forward P/E -803.4 25.6
Trailing P/E 28.2
Revenue (TTM)
Revenue Growth -0.2% 1.5%
Gross Margin 1.0% 0.9%
Operating Margin 0.0% -0.4%
EPS 1.57 -2.74
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, XOMA is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.